placebo
In the phase 3 trial, swollen joint counts improved by 47% in patients       receiving etanercept 25 mg compared with a 7% worsening in patients receiving       placebo.
In the phase 3 trial, swollen joint counts improved by 47% in patients       receiving etanercept 25 mg compared with a 7% worsening in  @OBJECT$   @PREDICAT$         @SUBJECT$ .